QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
OTCMKTS:IMUN

Immune Therapeutics (IMUN) Stock Price, News & Analysis

$0.09
0.00 (0.00%)
(As of 10/19/2023)
Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$0.07
$1.30
Volume
12 shs
Average Volume
15,246 shs
Market Capitalization
$7.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IMUN stock logo

About Immune Therapeutics Stock (OTCMKTS:IMUN)

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is based in Winter Park, Florida.

IMUN Stock Price History

IMUN Stock News Headlines

Biden fires warning shot for retirees...
Biden’s not holding back...He’s warned you that he plans to raise: Income taxes, death taxes, capital gains taxes & corporate taxes.Some or all of which WILL affect you or your family in one way or another…But it’s not too late… yet. Thousands of Americans are getting their FREE WEALTH PROTECTION KIT to discover the secret to protecting your retirement savings from Biden and inflation...
Biden fires warning shot for retirees...
Biden’s not holding back...He’s warned you that he plans to raise: Income taxes, death taxes, capital gains taxes & corporate taxes.Some or all of which WILL affect you or your family in one way or another…But it’s not too late… yet. Thousands of Americans are getting their FREE WEALTH PROTECTION KIT to discover the secret to protecting your retirement savings from Biden and inflation...
See More Headlines
Receive IMUN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:IMUN
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-3,540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.03) per share

Miscellaneous

Free Float
41,335,000
Market Cap
$7.78 million
Optionable
Not Optionable
Beta
0.46
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Kelly O'Brien Wilson (Age 51)
    Interim CEO, COO & Pres
    Comp: $53.83k
  • Ms. Noreen M. Griffin (Age 70)
    Exec. VP of Bus. Devel. & CEO
  • Mr. Glen A. Farmer M.B.A. (Age 54)
    Chief Financial Officer
  • Ms. Cynthia Douglas (Age 50)
    Company Sec.
  • Dr. Joseph M. Fortunak (Age 68)
    VP of Global R&D and Chemical Devel.














IMUN Stock Analysis - Frequently Asked Questions

How have IMUN shares performed in 2024?

Immune Therapeutics' stock was trading at $0.0930 at the start of the year. Since then, IMUN stock has increased by 0.0% and is now trading at $0.0930.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Immune Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Therapeutics investors own include Northwest Biotherapeutics (NWBO), Alexion Pharmaceuticals (ALXN), AK Steel (AKS), Galiano Gold (AKG), Agritek (AGTK), Agenus (AGEN), Affymetrix (AFFX), Advanced Disposal Services (ADSW), Adamis Pharmaceuticals (ADMP) and Analog Devices (ADI).

How do I buy shares of Immune Therapeutics?

Shares of IMUN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IMUN) was last updated on 2/20/2024 by MarketBeat.com Staff